Array Biopharma (ARRY) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.12 -7.41%
EPS Growth %: -52.0%
Financial Fact:
Interest income: 70K
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -52.0%
Financial Fact:
Interest income: 70K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q4 EPS of ($0.09), $0.07 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
- Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
